{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:37:03Z","timestamp":1790779023899,"version":"4.1.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T00:00:00Z","timestamp":1461196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Communaut\u00e9 de Travail des Pyr\u00e9n\u00e9es","award":["CTPP5\/12"],"award-info":[{"award-number":["CTPP5\/12"]}]},{"name":"charities CIEL, L'Un pour l'Autre and Ensangble","award":["09\/2013"],"award-info":[{"award-number":["09\/2013"]}]},{"name":"European Community Program SUDOE","award":["SOE2\/P1\/E341"],"award-info":[{"award-number":["SOE2\/P1\/E341"]}]},{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","award":["0057921"],"award-info":[{"award-number":["0057921"]}],"id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007391","name":"Association pour la Recherche sur le Cancer","doi-asserted-by":"publisher","award":["(DOC20121206007"],"award-info":[{"award-number":["(DOC20121206007"]}],"id":[{"id":"10.13039\/100007391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"La Ligue Contre le Cancer","doi-asserted-by":"crossref","award":["TDKB13362"],"award-info":[{"award-number":["TDKB13362"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004409","name":"Minist\u00e8re de l\u2019Enseignement Sup\u00e9rieur, de la Recherche Scientifique et des Technologies de l'Information et de la Communication","doi-asserted-by":"publisher","award":["DNV"],"award-info":[{"award-number":["DNV"]}],"id":[{"id":"10.13039\/501100004409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0150434","type":"journal-article","created":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T13:44:35Z","timestamp":1461246275000},"page":"e0150434","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":59,"title":["CD45 Isoform Profile Identifies Natural Killer (NK) Subsets with Differential Activity"],"prefix":"10.1371","volume":"11","author":[{"given":"Ewelina","family":"Krzywinska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie","family":"Cornillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea","family":"Allende-Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dang-Nghiem","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Rene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Yang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Pasero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Olive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Fegueux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Ceballos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosr","family":"Hicheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Sobecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Cartron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Villalba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,4,21]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.biocel.2012.04.024","article-title":"From tumor cell metabolism to tumor immune escape","volume":"45","author":"M Villalba","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3389\/fimmu.2013.00459","article-title":"Natural Killer Cells Modulation in Hematological Malignancies","volume":"4","author":"C Baier","year":"2013","journal-title":"Frontiers in immunology"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2174\/18715206113136660374","article-title":"Chemical metabolic inhibitors for the treatment of blood-borne cancers","volume":"14","author":"M Villalba","year":"2014","journal-title":"Anti-cancer agents in medicinal chemistry"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"e985924","DOI":"10.4161\/2162402X.2014.985924","article-title":"MHC-I modulation due to metabolic changes regulates tumor sensitivity to CTL and NK cells","volume":"4","author":"E Catal\u00e1n","year":"2015","journal-title":"Oncoimmunology"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1537-2995.2006.01145.x","article-title":"Good manufacturing practices production of natural killer cells for immunotherapy: a six-year single-institution experience","volume":"47","author":"DH McKenna Jr","year":"2007","journal-title":"Transfusion"},{"issue":"8","key":"ref6","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1182\/blood-2004-07-2974","article-title":"Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer","volume":"105","author":"JS Miller","year":"2005","journal-title":"Blood"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/CCO.0b013e3280148a1a","article-title":"Natural killer cell alloreactivity in allogeneic hematopoietic transplantation","volume":"19","author":"L Ruggeri","year":"2007","journal-title":"Curr Opin Oncol"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1200\/JCO.2009.24.4590","article-title":"NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia","volume":"28","author":"JE Rubnitz","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.biocel.2014.01.003","article-title":"All-trans retinoic acid (ATRA) induces miR-23a expression, decreases CTSC expression and granzyme B activity leading to impaired NK cell cytotoxicity","volume":"49","author":"D Sanchez-Martinez","year":"2014","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"e991613","DOI":"10.4161\/2162402X.2014.991613","article-title":"Human NK cells activated by EBV lymphoblastoid cells overcome anti-apoptotic mechanisms of drug resistance in haematological cancer cells","volume":"4","author":"D Sanchez-Martinez","year":"2015","journal-title":"Oncoimmunology"},{"issue":"8","key":"ref11","article-title":"IFN-\u03b1 signaling through PKC-\u03b8 is essential for anti-tumor NK cell function","volume":"3","author":"N Ram\u00edrez-Comet","year":"2014","journal-title":"Oncoimmunology"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.4049\/jimmunol.0801820","article-title":"Protein kinase C-theta is required for NK cell activation and in vivo control of tumor progression","volume":"182","author":"JI Aguilo","year":"2009","journal-title":"J Immunol"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000325265","article-title":"Molecular mechanisms of natural killer cell activation","volume":"3","author":"YT Bryceson","year":"2011","journal-title":"Journal of innate immunity"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"e51677","DOI":"10.1371\/journal.pone.0051677","article-title":"Human natural killer cell maturation defect supports in vivo CD56(bright) to CD56(dim) lineage development","volume":"7","author":"CI Domaica","year":"2012","journal-title":"PLoS One"},{"issue":"19","key":"ref15","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1182\/blood-2010-09-303057","article-title":"Dissecting CD56dim human NK cells","volume":"116","author":"L Moretta","year":"2010","journal-title":"Blood"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.smim.2014.02.008","article-title":"Human natural killer cell development in secondary lymphoid tissues","volume":"26","author":"AG Freud","year":"2014","journal-title":"Seminars in immunology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.ebiom.2015.08.021","article-title":"Identification of anti tumor cells carrying natural killer (NK) cell antigens in patients with hematological cancers","volume":"2","author":"E Krzywinska","year":"2015","journal-title":"EBioMedicine"},{"issue":"18","key":"ref18","doi-asserted-by":"crossref","first-page":"7000","DOI":"10.1073\/pnas.87.18.7000","article-title":"Cloning of three human tyrosine phosphatases reveals a multigene family of receptor-linked protein-tyrosine-phosphatases expressed in brain","volume":"87","author":"R Kaplan","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/ni.2246","article-title":"Protein tyrosine phosphatases in lymphocyte activation and autoimmunity","volume":"13","author":"I Rhee","year":"2012","journal-title":"Nat Immunol"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0092-8674(93)90302-7","article-title":"Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice","volume":"74","author":"K Kishihara","year":"1993","journal-title":"Cell"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1084\/jem.183.4.1707","article-title":"CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and B cell maturation","volume":"183","author":"KF Byth","year":"1996","journal-title":"J Exp Med"},{"issue":"9","key":"ref22","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1002\/(SICI)1521-4141(199909)29:09<2923::AID-IMMU2923>3.0.CO;2-Y","article-title":"Greatly reduced efficiency of both positive and negative selection of thymocytes in CD45 tyrosine phosphatase-deficient mice","volume":"29","author":"PJ Mee","year":"1999","journal-title":"Eur J Immunol"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/73208","article-title":"Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease","volume":"6","author":"C Kung","year":"2000","journal-title":"Nat Med"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.4049\/jimmunol.166.2.1308","article-title":"A deletion in the gene encoding the CD45 antigen in a patient with SCID","volume":"166","author":"EZ Tchilian","year":"2001","journal-title":"J Immunol"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nri1530","article-title":"Protein tyrosine phosphatases and the immune response","volume":"5","author":"T Mustelin","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"19228","DOI":"10.18632\/oncotarget.4653","article-title":"The presence of wild type p53 in hematological cancers improves the efficacy of combinational therapy targeting metabolism","volume":"6","author":"N Allende-Vega","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1600-065X.2008.00752.x","article-title":"CD45, CD148, and Lyp\/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells","volume":"228","author":"ML Hermiston","year":"2009","journal-title":"Immunol Rev"},{"issue":"8","key":"ref28","doi-asserted-by":"crossref","first-page":"e11966","DOI":"10.1371\/journal.pone.0011966","article-title":"NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs","volume":"5","author":"V Beziat","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1078\/0171-2985-00219","article-title":"Functional significance of the activation-associated receptors CD25 and CD69 on human NK-cells and NK-like T-cells","volume":"207","author":"J Clausen","year":"2003","journal-title":"Immunobiology"},{"issue":"8","key":"ref30","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1182\/blood-2009-11-253286","article-title":"CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells","volume":"116","author":"K Juelke","year":"2010","journal-title":"Blood"},{"issue":"19","key":"ref31","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood-2010-04-282301","article-title":"CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset","volume":"116","author":"S Lopez-Verges","year":"2010","journal-title":"Blood"},{"issue":"50","key":"ref32","doi-asserted-by":"crossref","first-page":"21647","DOI":"10.1073\/pnas.1012128107","article-title":"Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15\/IL-15Ralpha complexes","volume":"107","author":"KG Elpek","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"ref33","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1182\/blood-2012-06-437558","article-title":"A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission","volume":"120","author":"N Vey","year":"2012","journal-title":"Blood"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1042\/BJ20101825","article-title":"Regulation of cellular iron metabolism","volume":"434","author":"J Wang","year":"2011","journal-title":"Biochem J"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/sj.leu.2404499","article-title":"CD56(dim)CD16(+) NK cells downregulate CD16 following target cell induced activation of matrix metalloproteinases","volume":"21","author":"B Grzywacz","year":"2007","journal-title":"Leukemia"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"741","DOI":"10.4049\/jimmunol.1301024","article-title":"ADAM17-mediated shedding of FcgammaRIIIA on human NK cells: identification of the cleavage site and relationship with activation","volume":"192","author":"L Lajoie","year":"2014","journal-title":"J Immunol"},{"issue":"11","key":"ref37","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1182\/blood-2010-06-292219","article-title":"Differential requirements for CD45 in NK-cell function reveal distinct roles for Syk-family kinases","volume":"117","author":"DG Hesslein","year":"2011","journal-title":"Blood"},{"issue":"11","key":"ref38","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.4049\/jimmunol.176.11.6615","article-title":"Regulation of Ly49D\/DAP12 signal transduction by Src-family kinases and CD45","volume":"176","author":"LH Mason","year":"2006","journal-title":"J Immunol"},{"issue":"18","key":"ref39","doi-asserted-by":"crossref","first-page":"7012","DOI":"10.1073\/pnas.0601851103","article-title":"Dysregulation of signaling pathways in CD45-deficient NK cells leads to differentially regulated cytotoxicity and cytokine production","volume":"103","author":"DG Hesslein","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"ref40","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1084\/jem.20042294","article-title":"A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells","volume":"201","author":"ND Huntington","year":"2005","journal-title":"J Exp Med"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2567.2011.03464.x","article-title":"Human natural killer cells expressing the memory-associated marker CD45RO from tuberculous pleurisy respond more strongly and rapidly than CD45RO- natural killer cells following stimulation with interleukin-12","volume":"134","author":"X Fu","year":"2011","journal-title":"Immunology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0150434","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T12:40:27Z","timestamp":1540298427000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0150434"}},"subtitle":[],"editor":[{"given":"Pierre","family":"Bob\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,21]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0150434","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,21]]}}}